Human Growth Hormone (HGH) Market
Human Growth Hormone (HGH) Market Study by Growth Hormone Deficiency, Idiopathic Short Stature, Turner Syndrome, Small for Gestational Age, and Prader-Willi Syndrome From 2024 to 2034
Analysis of Human Growth Hormone (HGH) Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Human Growth Hormone (HGH) Market Outlook (2024 to 2034)
The global human growth hormone (HGH) market is evaluated to reach a valuation of US$ 6.76 billion in 2024 and further expand at a CAGR of 12.9% to end up at US$ 22.75 billion by the end of 2034.
An uncommon inherited bleeding condition called factor XIII deficiency is typified by a lack of clotting factor XIII. Specialized proteins called clotting factors are necessary for the blood to clot correctly. In particular, those who lack factor XIII experience lengthy face uncontrollable bleeding episodes because their blood clots are fragile and frequently break down. In addition to its effects on other bodily functions, factor XIII is recognized to be important for both pregnancy and healthy wound healing.
The rising awareness of growth hormones and their greater use in treating illnesses involving hormonal imbalance are among the reasons driving the market's rise. In addition, major R&D projects are carried out by top pharmaceutical and biopharmaceutical businesses in an attempt to commercialize new hormone therapy. These treatments seek to provide improved safety profiles and long-term activity, which will further propel the market's global expansion.
The need for hormone therapy has increased due to the rising prevalence of growth hormone shortages brought on by genetic illnesses, brain traumas, congenital abnormalities, and some medicinal procedures. In the UK, 1 in every 3,500 to 4,000 children is diagnosed with pediatric growth hormone insufficiency, according to the NCBI. The growth hormone business is also expanding because of continuous research and development efforts in this domain.
For instance, the European Union approved the sale of OPKO and Pfizer's once-weekly NGENLA (somatrogon) injection in February 2022. This injection is intended to treat juvenile growth hormone insufficiency.
To improve treatment results and avoid serious consequences, early diagnosis of endocrine disorders is essential. These illnesses include prolactinoma, hyperthyroidism/hypothyroidism, Graves' disease, Cushing's disease, Addison's disease, and Hashimoto thyroiditis.
| Report Attribute | Detail |
|---|---|
| Human Growth Hormone (HGH) Market Size (2024E) | US$ 6.76 Billion |
| Forecasted Market Value (2034F) | US$ 22.75 Billion |
| Global Market Growth Rate (2024 to 2034) | 12.9% CAGR |
| Eastern Europe Market Growth Rate (2024 to 2034) | 9.1% CAGR |
| Japan Market Value (2034F) | US$ 614.3 Million |
| North America Market Share (2024E) | 35.2% |
| East Asia Market Share (2034F) | 9.1% |
| Key Companies Profiled | Eli Lilly and Company; Emd Serono; Ankebio Co Ltd; Merck KGaA; Novo Nordisk; Novartis AG; Ferring BV; Ipsen S.A. |
Human growth hormone, also known as somatotropin or growth hormone, helps in the growth of all the essential tissues of the body, including bones. It is one of the most essential hormones required by the human body, which has been mentioned in the HGH industry outlook. Human growth hormone is produced and secreted by somatotrophs, anterior pituitary cells that secrete almost 1 to 2 milligrams of hormones daily.
Synthetic human growth hormone was developed in the 1980s and was approved by the FDA for use in children and adults, which has been stated in the HGH industry analysis. As per a study conducted by the Partnership Attitude Tracking Study (PATS), the usage of synthetic human growth hormones by teenagers has witnessed an increase.
Human growth hormone spurs muscle strength, growth, and exercise performance. Lower levels of human growth hormone increase the risk of diseases, hamper quality of life and initiate fat gain. Human growth hormone helps avoid several disorders, which include growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, Noonan syndrome, SHOX gene haploinsufficiency, idiopathic short stature, Creutzfeldt-Jakob disease, and chronic kidney diseases.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Human Growth Hormone (HGH) Market: Drivers
Long-acting human growth hormone formulations are consistently developing, according to the human growth hormone (HGH) industry outlook. Increase in the prevalence of human growth hormone deficiency, HIV/AIDS, cancer, Turner syndrome, SHOX gene haploinsufficiency, skeletal dysplasia, as well as increase in healthcare expenditure and the availability of advanced recombinant DNA technology are among factors expected to drive the market over the forecast period.
However, the costs of the R&D required for human growth hormone are incredibly high. The high cost of treatment is another factor restraining the growth of the human growth hormone market. Adverse effects of recombinant human growth hormones, which include joint & muscle pain, swelling in the legs & arms, increased insulin resistance, and carpal tunnel syndrome, are also expected to hamper the growth of the market over the forecast period.
Human Growth Hormone (HGH) Market: Overview
Growth deficiency syndrome is expected to contribute a significant share in the human growth hormone market owing to the increased incidence of pituitary dysfunctioning and growing support for the R&D of growth hormone drugs. Turner syndrome also plays a significant role in market growth, as stated in the human growth hormone (HGH) industry analysis.
A large number of patients suffering from Turner syndrome are treated by growth hormones for delayed sexual and physical development. The US FDA approved human growth hormone for the treatment of Turner syndrome in 1996. The others segment includes chronic kidney diseases, Down syndrome, skeletal dysplasia, Noonan syndrome, SHOX gene haploinsufficiency, and several other indications that are anticipated to boost the human growth hormone market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Human Growth Hormone (HGH) Market: Regional Outlook
North America’s human growth hormone market is anticipated to grow the fastest over the forecast period owing to the presence of local players in the market, easy availability, and better affordability for human growth hormone drugs and hormonal therapy.
Commercialization of human growth hormone drugs by the US. FDA over the years is also one of the vital factors boosting the human growth hormone market. The Asia-Pacific human growth hormone market is also expected to grow significantly over the forecast period because of improved healthcare expenditure, a large patient pool, and increasing investments by market players. Increasing awareness about treating short stature by human growth hormone is also propelling the human growth hormone market.
Human Growth Hormone (HGH) Market: Key Players
Some of the major market participants operating in the global HGH Market are :
- Eli Lilly and Company
- Emd Serono
- Ankebio Co Ltd
- Merck KGaA
- Novo Nordisk
- Novartis AG
- Ferring BV
- Ipsen S.A
Pfizer signed an agreement with OPKO for the developing and commercializing of the hGH-CTP human growth hormone for the treatment of adults and children. Novo Nordisk, in January 2015, received U.S. FDA approval for an injection pen, Norditropin FlexPro, for patients suffering from growth hormone disorders. The companies are competing for the production of long-acting drugs with lower adverse effects.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The report covers an exhaustive analysis of the following :
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Report Highlights :
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
Segmentation of the Human Growth Hormone (HGH) Market Research
-
By Application Type :
- Growth Hormone Deficiency
- Idiopathic Short Stature
- Turner Syndrome
- Small for Gestational Age
- Prader-Willi Syndrome
- Others
-
By Form :
- Hospitals
- Clinics
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Application Type
- 6.2. End Users
- 7. Global Market Analysis and Forecast, By Application Type
- 7.1. Growth hormone deficiency
- 7.2. Idiopathic short stature
- 7.3. Turner syndrome
- 7.4. Small for gestational age
- 7.5. Prader-Willi syndrome
- 7.6. Others
- 8. Global Market Analysis and Forecast, By End Users
- 8.1. Hospitals
- 8.2. Clinics
- 9. Global Market Analysis and Forecast, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. Eastern Europe
- 9.5. East Asia
- 9.6. South Asia & Pacific
- 9.7. MEA
- 10. North America Sales Analysis and Forecast, by Key Segments and Countries
- 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 15. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 16. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 17. Sales Forecast by Application Type and End Users for 30 Countries
- 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 19. Company Profile
- 19.1. Novo Nordisk
- 19.2. Eli
- 19.3. Lilly and company
- 19.4. Merck & Co. Inc.
- 19.5. Pfizer Inc.
- 19.6. Genentech Inc.
- 19.7. Ferring Holding SA
- 19.8. Sandoz International GmbH
- 19.9. Ipsen
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market US$ Mn Forecast by Region
Table 02: Global Market US$ Mn Forecast by Application Type
Table 03: Global Market US$ Mn Forecast by End Users
Table 04: North America Market US$ Mn Forecast by Country
Table 05: North America Market US$ Mn Forecast by Application Type
Table 06: North America Market US$ Mn Forecast by End Users
Table 07: Latin America Market US$ Mn Forecast by Country
Table 08: Latin America Market US$ Mn Forecast by Application Type
Table 09: Latin America Market US$ Mn Forecast by End Users
Table 10: Western Europe Market US$ Mn Forecast by Country
Table 11: Western Europe Market US$ Mn Forecast by Application Type
Table 12: Western Europe Market US$ Mn Forecast by End Users
Table 13: Eastern Europe Market US$ Mn Forecast by Country
Table 14: Eastern Europe Market US$ Mn Forecast by Application Type
Table 15: Eastern Europe Market US$ Mn Forecast by End Users
Table 16: East Asia Market US$ Mn Forecast by Country
Table 17: East Asia Market US$ Mn Forecast by Application Type
Table 18: East Asia Market US$ Mn Forecast by End Users
Table 19: South Asia & Pacific Market US$ Mn Forecast by Country
Table 20: South Asia & Pacific Market US$ Mn Forecast by Application Type
Table 21: South Asia & Pacific Market US$ Mn Forecast by End Users
Table 22: MEA Market US$ Mn Forecast by Country
Table 23: MEA Market US$ Mn Forecast by Application Type
Table 24: MEA Market US$ Mn Forecast by End Users
Table 25: North America Market US$ Mn Forecast by Country
Table 26: North America Market US$ Mn Forecast by Application Type
Table 27: North America Market US$ Mn Forecast by End Users
Table 28: Latin America Market US$ Mn Forecast by Country
Table 29: Latin America Market US$ Mn Forecast by Application Type
Table 30: Latin America Market US$ Mn Forecast by End Users
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application Type
Figure 02: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 03: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 04: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application Type
Figure 05: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 06: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 07: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application Type
Figure 08: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 09: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 10: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application Type
Figure 11: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 12: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application Type
Figure 14: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 15: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 16: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application Type
Figure 17: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 18: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 19: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application Type
Figure 20: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 21: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 22: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application Type
Figure 23: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 24: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application Type
Figure 26: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 27: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 28: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Application Type
Figure 29: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End Users
Figure 30: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the size of the market?
The market for human growth hormones is estimated to reach a worth of US$ 6.76 billion in 2024.
What is the forecasted size of the market?
The global market is projected to reach US$ 22.75 billion by the end of 2034.
Human Growth Hormone (HGH) Market